A detailed history of Bessemer Group Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bessemer Group Inc holds 17,901 shares of BDX stock, worth $4.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,901
Previous 16,456 8.78%
Holding current value
$4.08 Million
Previous $3.84 Million 12.28%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$221.47 - $242.41 $320,024 - $350,282
1,445 Added 8.78%
17,901 $4.32 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $2.91 Million - $3.18 Million
-12,926 Reduced 43.99%
16,456 $3.84 Million
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $353,209 - $374,815
1,513 Added 5.43%
29,382 $7.27 Million
Q4 2023

Feb 09, 2024

BUY
$232.24 - $267.23 $2.36 Million - $2.72 Million
10,161 Added 57.38%
27,869 $6.8 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $464,427 - $516,700
1,822 Added 11.47%
17,708 $4.58 Million
Q2 2023

Aug 10, 2023

SELL
$238.39 - $265.32 $168,303 - $187,315
-706 Reduced 4.26%
15,886 $4.19 Million
Q1 2023

May 10, 2023

SELL
$229.71 - $259.35 $120,827 - $136,418
-526 Reduced 3.07%
16,592 $4.11 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $550,309 - $647,670
-2,521 Reduced 12.84%
17,118 $4.35 Million
Q3 2022

Nov 09, 2022

BUY
$51.03 - $264.23 $169,776 - $879,093
3,327 Added 20.4%
19,639 $4.38 Million
Q2 2022

Aug 10, 2022

BUY
$234.74 - $275.42 $334,739 - $392,748
1,426 Added 9.58%
16,312 $4.02 Million
Q1 2022

May 12, 2022

BUY
$243.64 - $270.48 $10,720 - $11,901
44 Added 0.3%
14,886 $3.96 Million
Q4 2021

Jan 27, 2022

BUY
$230.08 - $250.94 $707,956 - $772,142
3,077 Added 26.15%
14,842 $3.73 Million
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $145,915 - $160,806
-627 Reduced 5.06%
11,765 $2.89 Million
Q2 2021

Aug 06, 2021

SELL
$232.65 - $254.58 $1.32 Million - $1.45 Million
-5,681 Reduced 31.43%
12,392 $3.01 Million
Q1 2021

May 13, 2021

SELL
$232.09 - $256.88 $947,391 - $1.05 Million
-4,082 Reduced 18.42%
18,073 $4.29 Million
Q4 2020

Feb 09, 2021

SELL
$221.92 - $245.94 $1.48 Million - $1.64 Million
-6,673 Reduced 23.15%
22,155 $5.54 Million
Q3 2020

Nov 12, 2020

SELL
$215.77 - $276.76 $111,121 - $142,531
-515 Reduced 1.76%
28,828 $6.71 Million
Q2 2020

Aug 05, 2020

SELL
$219.9 - $263.41 $12,534 - $15,014
-57 Reduced 0.19%
29,343 $7.02 Million
Q1 2020

Apr 30, 2020

BUY
$195.69 - $279.01 $2.64 Million - $3.76 Million
13,477 Added 84.64%
29,400 $6.76 Million
Q4 2019

Feb 04, 2020

SELL
$236.45 - $266.82 $899,219 - $1.01 Million
-3,803 Reduced 19.28%
15,923 $4.33 Million
Q3 2019

Nov 07, 2019

SELL
$230.58 - $256.08 $92.4 Million - $103 Million
-400,759 Reduced 95.31%
19,726 $4.99 Million
Q2 2019

Jul 19, 2019

SELL
$217.4 - $246.08 $59.2 Million - $67 Million
-272,101 Reduced 39.29%
420,485 $106 Million
Q1 2019

May 13, 2019

SELL
$206.05 - $248.17 $56.5 Million - $68.1 Million
-274,347 Reduced 28.37%
692,586 $173 Million
Q4 2018

Feb 12, 2019

SELL
$204.73 - $257.93 $15.1 Million - $19.1 Million
-73,860 Reduced 7.1%
966,933 $218 Million
Q3 2018

Nov 06, 2018

BUY
$233.07 - $256.0 $818,541 - $899,072
3,512 Added 0.34%
1,040,793 $272 Million
Q2 2018

Jul 25, 2018

BUY
$208.1 - $233.85 $3.94 Million - $4.43 Million
18,953 Added 1.86%
1,037,281 $248 Million
Q1 2018

May 10, 2018

BUY
$205.46 - $240.27 $3.63 Million - $4.24 Million
17,654 Added 1.76%
1,018,328 $221 Million
Q4 2017

Jan 30, 2018

BUY
$189.0 - $222.64 $2.54 Million - $2.99 Million
13,448 Added 1.36%
1,000,674 $214 Million
Q3 2017

Nov 03, 2017

BUY
$186.89 - $198.9 $185 Million - $196 Million
987,226
987,226 $193 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.